Enento Group Plc: SHARE REPURCHASE 3.1.2024
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
| Enento Group Plc | ANNOUNCEMENT 3.1.2024 | |
| Enento Group Plc: SHARE REPURCHASE 3.1.2024 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 3.1.2024 | |
| Bourse trade | Buy | |
| Share | ENENTO | |
| Amount | 2,543 | Shares |
| Average price/ share | 18.9358 | EUR |
| Total cost | 48,153.74 | EUR |
| Enento Group Plc now holds a total of 14 000 shares | ||
| including the shares repurchased on 3.1.2024 | ||
| On behalf of Enento Group Plc | ||
| Nordea Bank Oyj | ||
| Janne Sarvikivi | Sami Huttunen | |
| For further information: | ||
| Arto Paukku | ||
| Investor Relations Officer | ||
| tel. +358 50 469 5380 | ||
| www.enento.com | ||
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AirTripMaker Launches Comprehensive Flight Tickets to India Routes Guide from the USA and Canada to Major Indian Destinations
- Best Protective iPhone Cases for 2026: Top Slim and Drop-Protection Options for iPhone 18 Pro & iPhone 18 Pro Max Recommended by Consumer365
- Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
